Drug Ther Bull. 1999 Jul;37(7):55-6. doi: 10.1136/dtb.1999.37755.
In March this year, we held our seventh annual symposium entitled: 'Who decides on treatment: the patient versus the State'. Within the NHS, there are many levels at which treatment decisions are made. At one extreme, decisions involve individuals at the point of 'delivery' and so are taken during the consultation and involving the patient and prescriber. At the other extreme, decisions are a national matter and taken by government. The symposium explored the changing environments of decision-making and the contribution of those involved. Here we summarise the talks and incorporate ideas that arose in discussion.
今年3月，我们举办了第七届年度研讨会，主题为：“谁来决定治疗方案：患者还是国家”。在英国国家医疗服务体系（NHS）内，治疗决策是在多个层面做出的。一方面，决策涉及“提供”治疗的个人，因此是在会诊期间由患者和开处方者做出的。另一方面，决策是国家层面的事务，由政府做出。本次研讨会探讨了决策环境的变化以及相关人员的贡献。在此，我们总结了演讲内容，并纳入了讨论中提出的观点。
